127 related articles for article (PubMed ID: 30219827)
21. Oxysterol-binding protein is a phosphatidylinositol 4-kinase effector required for HCV replication membrane integrity and cholesterol trafficking.
Wang H; Perry JW; Lauring AS; Neddermann P; De Francesco R; Tai AW
Gastroenterology; 2014 May; 146(5):1373-85.e1-11. PubMed ID: 24512803
[TBL] [Abstract][Full Text] [Related]
22. Establishment of robust HCV genotype 4d, 5a, and 6a replicon systems.
Camus G; Xu S; Han B; Lu J; Dvory-Sobol H; Yu M; Cheng G; Miller MD; Doehle BP; Mo H
Virology; 2018 Jan; 514():134-141. PubMed ID: 29175627
[TBL] [Abstract][Full Text] [Related]
23. A reporter-based assay for identifying hepatitis C virus inhibitors based on subgenomic replicon cells.
Lee JC; Chang CF; Chi YH; Hwang DR; Hsu JT
J Virol Methods; 2004 Mar; 116(1):27-33. PubMed ID: 14715304
[TBL] [Abstract][Full Text] [Related]
24. New small-molecule inhibitors effectively blocking picornavirus replication.
Ford Siltz LA; Viktorova EG; Zhang B; Kouiavskaia D; Dragunsky E; Chumakov K; Isaacs L; Belov GA
J Virol; 2014 Oct; 88(19):11091-107. PubMed ID: 25008939
[TBL] [Abstract][Full Text] [Related]
25. Class III phosphatidylinositol 4-kinase alpha and beta are novel host factor regulators of hepatitis C virus replication.
Borawski J; Troke P; Puyang X; Gibaja V; Zhao S; Mickanin C; Leighton-Davies J; Wilson CJ; Myer V; Cornellataracido I; Baryza J; Tallarico J; Joberty G; Bantscheff M; Schirle M; Bouwmeester T; Mathy JE; Lin K; Compton T; Labow M; Wiedmann B; Gaither LA
J Virol; 2009 Oct; 83(19):10058-74. PubMed ID: 19605471
[TBL] [Abstract][Full Text] [Related]
26. Double-stranded RNA-activated protein kinase inhibits hepatitis C virus replication but may be not essential in interferon treatment.
Chang JH; Kato N; Muroyama R; Taniguchi H; Guleng B; Dharel N; Shao RX; Tateishi K; Jazag A; Kawabe T; Omata M
Liver Int; 2010 Feb; 30(2):311-8. PubMed ID: 19840259
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of hepatitis C virus replication by semi-synthetic derivatives of glycopeptide antibiotics.
Obeid S; Printsevskaya SS; Olsufyeva EN; Dallmeier K; Durantel D; Zoulim F; Preobrazhenskaya MN; Neyts J; Paeshuyse J
J Antimicrob Chemother; 2011 Jun; 66(6):1287-94. PubMed ID: 21436155
[TBL] [Abstract][Full Text] [Related]
28. Soraphen A: A broad-spectrum antiviral natural product with potent anti-hepatitis C virus activity.
Koutsoudakis G; Romero-Brey I; Berger C; Pérez-Vilaró G; Monteiro Perin P; Vondran FW; Kalesse M; Harmrolfs K; Müller R; Martinez JP; Pietschmann T; Bartenschlager R; Brönstrup M; Meyerhans A; Díez J
J Hepatol; 2015 Oct; 63(4):813-21. PubMed ID: 26070407
[TBL] [Abstract][Full Text] [Related]
29. Cytosolic phospholipase A2 gamma is involved in hepatitis C virus replication and assembly.
Xu S; Pei R; Guo M; Han Q; Lai J; Wang Y; Wu C; Zhou Y; Lu M; Chen X
J Virol; 2012 Dec; 86(23):13025-37. PubMed ID: 23015700
[TBL] [Abstract][Full Text] [Related]
30. Selectable subgenomic and genome-length dicistronic RNAs derived from an infectious molecular clone of the HCV-N strain of hepatitis C virus replicate efficiently in cultured Huh7 cells.
Ikeda M; Yi M; Li K; Lemon SM
J Virol; 2002 Mar; 76(6):2997-3006. PubMed ID: 11861865
[TBL] [Abstract][Full Text] [Related]
31. Suppression of hepatitis C virus by the flavonoid quercetin is mediated by inhibition of NS3 protease activity.
Bachmetov L; Gal-Tanamy M; Shapira A; Vorobeychik M; Giterman-Galam T; Sathiyamoorthy P; Golan-Goldhirsh A; Benhar I; Tur-Kaspa R; Zemel R
J Viral Hepat; 2012 Feb; 19(2):e81-8. PubMed ID: 22239530
[TBL] [Abstract][Full Text] [Related]
32. Kinases required in hepatitis C virus entry and replication highlighted by small interference RNA screening.
Trotard M; Lepère-Douard C; Régeard M; Piquet-Pellorce C; Lavillette D; Cosset FL; Gripon P; Le Seyec J
FASEB J; 2009 Nov; 23(11):3780-9. PubMed ID: 19608626
[TBL] [Abstract][Full Text] [Related]
33. Effect of alpha interferon on the hepatitis C virus replicon.
Guo JT; Bichko VV; Seeger C
J Virol; 2001 Sep; 75(18):8516-23. PubMed ID: 11507197
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of hepatitis C virus replication by a specific inhibitor of serine-arginine-rich protein kinase.
Karakama Y; Sakamoto N; Itsui Y; Nakagawa M; Tasaka-Fujita M; Nishimura-Sakurai Y; Kakinuma S; Oooka M; Azuma S; Tsuchiya K; Onogi H; Hagiwara M; Watanabe M
Antimicrob Agents Chemother; 2010 Aug; 54(8):3179-86. PubMed ID: 20498328
[TBL] [Abstract][Full Text] [Related]
35. Evidence that enviroxime targets multiple components of the rhinovirus 14 replication complex.
Brown-Augsburger P; Vance LM; Malcolm SK; Hsiung H; Smith DP; Heinz BA
Arch Virol; 1999; 144(8):1569-85. PubMed ID: 10486111
[TBL] [Abstract][Full Text] [Related]
36. Characterization of the inhibition of hepatitis C virus RNA replication by nonnucleosides.
Tomei L; Altamura S; Bartholomew L; Bisbocci M; Bailey C; Bosserman M; Cellucci A; Forte E; Incitti I; Orsatti L; Koch U; De Francesco R; Olsen DB; Carroll SS; Migliaccio G
J Virol; 2004 Jan; 78(2):938-46. PubMed ID: 14694125
[TBL] [Abstract][Full Text] [Related]
37. Cyclophilin and NS5A inhibitors, but not other anti-hepatitis C virus (HCV) agents, preclude HCV-mediated formation of double-membrane-vesicle viral factories.
Chatterji U; Bobardt M; Tai A; Wood M; Gallay PA
Antimicrob Agents Chemother; 2015 May; 59(5):2496-507. PubMed ID: 25666154
[TBL] [Abstract][Full Text] [Related]
38. Sulforaphane Suppresses Hepatitis C Virus Replication by Up-Regulating Heme Oxygenase-1 Expression through PI3K/Nrf2 Pathway.
Yu JS; Chen WC; Tseng CK; Lin CK; Hsu YC; Chen YH; Lee JC
PLoS One; 2016; 11(3):e0152236. PubMed ID: 27023634
[TBL] [Abstract][Full Text] [Related]
39. A serine palmitoyltransferase inhibitor blocks hepatitis C virus replication in human hepatocytes.
Katsume A; Tokunaga Y; Hirata Y; Munakata T; Saito M; Hayashi H; Okamoto K; Ohmori Y; Kusanagi I; Fujiwara S; Tsukuda T; Aoki Y; Klumpp K; Tsukiyama-Kohara K; El-Gohary A; Sudoh M; Kohara M
Gastroenterology; 2013 Oct; 145(4):865-73. PubMed ID: 23791700
[TBL] [Abstract][Full Text] [Related]
40. Modulation of hepatitis C virus genome replication by glycosphingolipids and four-phosphate adaptor protein 2.
Khan I; Katikaneni DS; Han Q; Sanchez-Felipe L; Hanada K; Ambrose RL; Mackenzie JM; Konan KV
J Virol; 2014 Nov; 88(21):12276-95. PubMed ID: 25122779
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
